Tumor progression, however, faces resistance from type 1 lymphocytes (Th1 CD4+ T cells, CD8+ T cells, NK cells, and γδ T cells) and collaborating innate cells (dendritic cells, M1 macrophages, and N1 neutrophils). The gene discussed is CD8A; the disease is neoplasm.